ERBB2 and breast carcinoma: In both ER-and ER+ breast cancer we observed a strong correlation between the ERBB2, RAS and AKT pathways (Pearson correlation between RAS and AKT was 0.61 in ER+ and 0.59 in ER-), consistent with AKT-signalling a direct downstream target of RAS and ERBB2 [3,58,59].